EnriqueAlvarezIIIMDPhD

PubMed

• Advances in Multiple Sclerosis Neurotherapeutics, Neuroprotection, and Risk Mitigation Strategies.
  Ahmad Abdelrahman, Enrique Alvarez> ;Neurologic Clinics. 2024 Feb 1
• Comparative Efficacy of Disease-Modifying Treatments for Relapsing Multiple Sclerosis-Variations in Real-World Experience.
  Andrew B Wolf, Enrique Alvarez, John R Corboy> ;JAMA Neurology. 2024 Jan 1
• 1 citations
  Implementing Shared Decision-Making for Multiple Sclerosis: The MS-SUPPORT Tool.
  Nananda F Col, Andrew J Solomon, Enrique Alvarez, Lori Pbert, Carolina Ionete, Idanis BerriosMorales, Jennifer Chester, Christen Kutz, Crystal Iwuchukwu, Terrie Living...> ;Multiple Sclerosis and Related Disorders. 2023 Dec 1
• 1 citations
  Feasibility of Low-Load Resistance Training Using Blood Flow Restriction for People With Advanced Multiple Sclerosis: A Prospective Cohort Study.
  Mark M Mañago, Evan T Cohen, Enrique Alvarez, Emily R Hager, Johnny G Owens, Michael Bade> ;Physical Therapy. 2024 Jan 1
• 1 citations
  Plasma IgG aggregates as biomarkers for multiple sclerosis.
  Wenbo Zhou, Michael Graner, Cheryl Beseler, Timothy Domashevich, Sean Selva, Gill Webster, Aurelie Ledreux, Zoe Zizzo, Max Lundt, Enrique Alvarez, Xiaoli Yu> ;Clinical Immunology. 2023 Nov 1
• 1 citations
  Secondary hypogammaglobulinemia in patients with multiple sclerosis on anti-CD20 therapy: Pathogenesis, risk of infection, and disease management.
  Enrique Alvarez, Erin E Longbrake, Kottil W Rammohan, James Stankiewicz, Carrie M Hersh> ;Multiple Sclerosis and Related Disorders. 2023 Nov 1
• 4 citations
  Multiple sclerosis plasma IgG aggregates induce complement-dependent neuronal apoptosis.
  Wenbo Zhou, Michael Graner, Petr Paucek, Cheryl Beseler, Matthew Boisen, Andrew Bubak, Francisco Asturias, Woro George, Arin Graner, David Ormond, Timothy Vollmer, Enr...> ;Cell Death & Disease. 2023 Apr 8
• 2 citations
  Metabolic costs of walking and arm reaching in persons with mild multiple sclerosis.
  Robert J Courter, Enrique Alvarez, Roger M Enoka, Alaa A Ahmed> ;Journal of Neurophysiology. 2023 Apr 1
• 1 citations
  Safety and patient experience with at-home infusion of ocrelizumab for multiple sclerosis.
  Britney Barrera, Haley Simpson, Eric Engebretson, Stefan Sillau, Brooke Valdez, José Parra-González, Ryan C Winger, Lou Anne Epperson, Ashley Banks, Kathryn Pierce, Me...> ;Annals of Clinical and Translational Neurology. 2023 Apr 1
• 7 citations
  The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome.
  Erin E Longbrake, Le H Hua, Ellen M Mowry, Susan A Gauthier, Enrique Alvarez, Anne H Cross, Jinglan Pei, Jessica Priest, Catarina Raposo, David A Hafler, Ryan C Winger> ;Multiple Sclerosis and Related Disorders. 2022 Dec 1
• 3 citations
  A double-blind, placebo-controlled, single-ascending-dose intravenous infusion study of rHIgM22 in subjects with multiple sclerosis immediately following a relapse.
  Benjamin M Greenberg, James D Bowen, Enrique Alvarez, Moses Rodriguez, Anthony O Caggiano, Arthur E Warrington, Ping Zhao, Andrew Eisen> ;Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2022 Apr 26
• 3 citations
  Tolerability and Safety of Switching from Rituximab to Ocrelizumab: Evaluating Factors Associated with Infusion Related Reactions.
  Enrique Alvarez, Kavita V Nair, Stefan Sillau, Ian Shelton, Rebecca Seale, Sean Selva, John Corboy, Timothy L Vollmer> ;Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2022 Jan 5
• 5 citations
  Evaluation of Plasma Neurofilament Light Chain Levels as a Biomarker of Neuronal Injury in the Active and Chronic Phases of Autoimmune Neurologic Disorders.
  Ryan Kammeyer, Christopher Mizenko, Stefan Sillau, Alanna Richie, Gregory Owens, Kavita V Nair, Enrique Alvarez, Timothy L Vollmer, Jeffrey L Bennett, Amanda L Piquet> ;Frontiers in Neurology. 2022 Jan 1
• 16 citations
  Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIO...
  Tjalf Ziemssen, Douglas L Arnold, Enrique Alvarez, Anne H Cross, Roman Willi, Bingbing Li, Petra Kukkaro, Harald Kropshofer, Krishnan Ramanathan, Martin Merschhemke, B...> ;Frontiers in Immunology. 2022 Jan 1
• 9 citations
  B cell depletion changes the immune cell profile in multiple sclerosis patients: One-year report.
  Amy E. Lovett-Racke, Yuhong Yang, Yue Liu, Matthew Gormley, Emma E. Kraus, Calsey Graham, Sibyl Wray, Michael K. Racke, Enrique Alvarez, Ann D Bass, Edward Fox> ;Journal of Neuroimmunology. 2021 Oct 15
• 5 citations
  Treatment with electrical stimulation of sensory nerves improves motor function and disability status in persons with multiple sclerosis: A pilot study.
  Mohammed Alenazy, Sajjad Daneshgar Asl, Luca Petrigna, Kaltrina Feka, Enrique Alvarez, Awad M. Almuklass, Roger M. Enoka> ;Journal of Electromyography and Kinesiology. 2021 Oct 13
• 26 citations
  Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study
  Amit Bar-Or, Heinz Wiendl, Xavier Montalban, Enrique Alvarez, M. V. Davydovskaya, Silvia Delgado, E. P. Evdoshenko, Natasa Giedraitiene, Katrin Gross-Paju, Sulev Haldr...> ;Multiple Sclerosis. 2021 Oct 4
• 48 citations
  Distinguishing between Fatigue and Fatigability in Multiple Sclerosis
  Roger M. Enoka, Awad M. Almuklass, Mohammed Alenazy, Enrique Alvarez, Jacques Duchateau> ;Neurorehabilitation and Neural Repair. 2021 Sep 28
• 20 citations
  Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial.
  Daniel Ontaneda, Pascal Sati, Praneeta C. Raza, M Kilbane, E Gombos, Enrique Alvarez, Christina J. Azevedo, Peter A. Calabresi, J. A. Cohen, L Freeman, Roland G. Henry...> ;Neuroimage. Clinical. 2021 Sep 23
• 27 citations
  Multiple Sclerosis Phenotypes as a Continuum: The Role of Neurologic Reserve.
  Timothy Vollmer, Kavita V. Nair, Ian M. Williams, Enrique Alvarez> ;Neurology. Clinical Practice. 2021 Aug 1
• 7 citations
  COVID-19 Vaccination in Patients With Multiple Sclerosis on Disease-Modifying Therapy.
  Andrew B. Wolf, Enrique Alvarez> ;Neurology. Clinical Practice. 2021 Aug 1
• 8 citations
  Brain atrophy rates in patients with multiple sclerosis on long term natalizumab resembles healthy controls.
  Enrique Alvarez, Kavita V. Nair, Brian D. Hoyt, Rebecca A. Seale, Stefan Sillau, Augusto Miravalle, Eric Engebretson, Brittany Schurr, John R. Corboy, Timothy Vollmer,...> ;Multiple Sclerosis and Related Disorders. 2021 Jul 24
• 2 citations
  Movement compensations during a step ascent task are associated with stair climbing performance in people with multiple sclerosis.
  Paul W. Kline, Cory L. Christiansen, Emily R. Hager, Enrique Alvarez, Mark M Mañago> ;Gait & Posture. 2021 Apr 15
• 9 citations
  Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey
  Tjalf Ziemssen, Gavin Giovannoni, Enrique Alvarez, Virender Bhan, Carrie M. Hersh, Olaf Hoffmann, Celia Oreja-Guevara, Rene R Robles-Cedeño, Maria Trojano, Patrick Ver...> ;Journal of Medical Internet Research. 2021 Oct 6
• 2 citations
  Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era.
  Jacqueline Nicholas, Robert K. Shin, Enrique Alvarez, Barry Hendin, Kavita V. Nair, Fred D. Lublin> ;Multiple Sclerosis and Related Disorders. 2021 Apr 1
• Join now to see all